Abbott Laboratories Share Price Today: Live Updates & Key Insights

Abbott Laboratories share price today is $107.81, up -0.14%. The stock opened at $107.02 against the previous close of $107.96, with an intraday high of $107.95 and low of $106.215.

Abbott Laboratories Share Price Chart

Abbott Laboratories

us-stock
To Invest in {{usstockname}}
us-stock

Abbott Laboratories Share Price Performance

$107.81 -0.0014(-0.14%) ABT at 10 Aug 2026 05:44 PM Medical Devices
Lowest Today 106.215
Highest Today 107.95
Today’s Open 107.02
Prev. Close 107.96
52 Week High 134.38
52 Week Low 81.39
Day’s Range: Low 106.215 High 107.95
52-Week Range: Low 81.39 High 134.38
1 day return -
1 Week return +0.59
1 month return +14.24
3 month return +30.58
6 month return -2.95
1 year return -17.98
3 year return +2.44
5 year return -12.47
10 year return -

Abbott Laboratories Institutional Holdings

BlackRock Inc 8.42

Vanguard Capital Management, LLC 6.53

State Street Corp 4.60

Vanguard Morn Total Stk Mkt Idx Investor 3.20

Capital Research Global Investors 2.88

Vanguard Portfolio Management, LLC 2.77

Schwab US Dividend Equity ETF™ 2.63

Charles Schwab Investment Management Inc 2.63

Vanguard 500 Index Investor 2.61

Geode Capital Management, LLC 2.26

Capital Research & Mgmt Co - Division 3 2.17

Morgan Stanley - Brokerage Accounts 1.74

Wellington Management Company LLP 1.56

JPMorgan Chase & Co 1.55

iShares Core S&P 500 ETF 1.36

Fidelity 500 Index 1.29

State Street® SPDR® S&P 500® ETF 1.24

Franklin Resources Inc 1.16

Northern Trust Corp 1.12

Bank of America Corp 1.11

American Funds Washington Mutual A 1.03

Capital Group Wash Mutual Invtrs Comp 1.03

T. Rowe Price Associates, Inc. 1.00

Vanguard Morn Value Index Investor 0.96

Wells Fargo & Co 0.92

Massachusetts Financial Services Company 0.90

The Goldman Sachs Group Inc 0.84

Ameriprise Financial Inc 0.82

Deutsche Bank AG 0.81

State Street®HlthCrSelSectSPDR®ETF 0.72

American Funds Invmt Co of Amer A 0.60

Capital Group Investment Co of Amer Comp 0.60

Vanguard Dividend Appreciation ETF 0.57

Vanguard Institutional Index I 0.55

State St S&P 500® Idx SL Cl I 0.53

Vanguard Health Care Inv 0.48

Vanguard Institutional 500 Index Trust 0.45

Vanguard Wellington Inv 0.40

MFS Large Cap Value Equity 0.40

Vanguard High Dividend Yield ETF 0.40

Abbott Laboratories Market Status

Strong Buy: 16

Buy: 4

Hold: 7

Sell: 0

Strong Sell: 0

Abbott Laboratories Fundamentals

Market Cap 186812.19 M

PB Ratio 3.5786

PE Ratio 34.273

Enterprise Value 209906.51 M

Total Assets 86713.00 M

Volume 6606637

Abbott Laboratories Company Financials

Annual Revenue FY25:44328000000 44328.0M, FY24:41950000000 41950.0M, FY23:39959000000 39959.0M, FY22:43653000000 43653.0M, FY21:43075000000 43075.0M

Annual Profit FY25:24607000000 24607.0M, FY24:23244000000 23244.0M, FY23:21947000000 21947.0M, FY22:24511000000 24511.0M, FY21:24538000000 24538.0M

Annual Net worth FY25:6524000000 6524.0M, FY24:13402000000 13402.0M, FY23:5162000000 5162.0M, FY22:6933000000 6933.0M, FY21:7071000000 7071.0M

Quarterly Revenue Q2/2026:12593000000 12593.0M, Q1/2026:11164000000 11164.0M, Q4/2025:11459000000 11459.0M, Q3/2025:11369000000 11369.0M, Q2/2025:11142000000 11142.0M

Quarterly Profit Q2/2026:7304000000 7304.0M, Q1/2026:6283000000 6283.0M, Q4/2025:6537000000 6537.0M, Q3/2025:6338000000 6338.0M, Q2/2025:6288000000 6288.0M

Quarterly Net worth Q2/2026:928000000 928.0M, Q1/2026:1077000000 1077.0M, Q4/2025:1776000000 1776.0M, Q3/2025:1644000000 1644.0M, Q2/2025:1779000000 1779.0M

About Abbott Laboratories & investment objective

Company Information Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Organisation Medical Devices

Employees 122000

Industry Medical Devices

CEO Mr. Robert B. Ford

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Abbott Laboratories FAQs

What is the share price of Abbott Laboratories today?

The current share price of Abbott Laboratories is $107.81.

Can I buy Abbott Laboratories shares in India?

Yes, Indian investors can buy Abbott Laboratories shares by opening an international trading and demat account with Motilal Oswal.

How to buy Abbott Laboratories shares in India?

You can easily invest in Abbott Laboratories shares from India by:

Can I buy fractional shares of Abbott Laboratories?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Abbott Laboratories?

Abbott Laboratories has a market cap of $186812.19 M.

In which sector does Abbott Laboratories belong?

Abbott Laboratories operates in the Medical Devices sector.

What documents are required to invest in Abbott Laboratories stocks?

To invest, you typically need:

What is the PE and PB ratio of Abbott Laboratories?

The PE ratio of Abbott Laboratories is 34.27 and the PB ratio is 3.58.